Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma

Oral Diseases

Volumn 13, Issue 3, 2007, Pages 285-290

  Diniz Freitas, M ^a,b   Garcia Caballero T ^a   Antunez Lopez J ^a   Gandara Rey J M ^a   Garcia Garcia A ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anti EGFR therapy; Cell proliferation (MIB1 labelling index); Epidermal growth factor receptor; Immunohistochemistry; Squamous cell carcinoma

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; DISEASE COURSE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAGENT KITS, DIAGNOSTIC; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 34247373146     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2006.01280.x     Document Type: Article

References (25)

1. Bankfalvi A, Krabort M, Vegh A, Felszeghy E, Piffko J (2003). Deranged expression of the E-cadherin/β-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31 : 450 457.
2. Bergler W, Bier H, Ganzer U (1998). The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Arch Otorhinolaryngol 246 : 121 125.
3. Bettendorf O, Piffko J, Bànkfalvi A (2004). Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy Oral Oncol 40 : 110 119.
4. Christensen ME, Engbaeck F, Therkildsen, Bretlau P, Nexo E (1995). A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations. Br J Cancer 72 : 1487 1493.
5. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A (2006). Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42 : 190 200.
6. Field JK, Spandidos DA (1987). Expression of oncogenes in human tumours with special reference to the head and neck region. J Oral Pathol 16 : 97 107.
7. Gamboa-Rodríguez A, Domínguez-Fonseca C, Quintanilla-Martínez L et al (2004). Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinomas from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system. Mod Pathol 17 : 579 587.
8. Gonzalez-Moles M, Esteban F, Rodríguez-Archilla A, Ruiz-Avila, Gonzalez-Moles S (2002). Importance of tumour thickness measurement in prognosis of tongue cancer. Oral Oncol 38 : 394 397.
9. Hibbert J, Marks NJ, Winter PJ, Shaheen OH (1983). Prognostic factors in oral squamous carcinoma and their relation to clinical staging. Clin Otolaryngol Allied Sci 8 : 197 203.
10. Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 : 457 481.
11. Keçicki T, Jelen M, Zalesska-Krçicka M, Rak J, Szkudlarek T, Jelen-Krzeszewska J (1999). Epidermal growth factor receptor (EGFR), proliferating cell nuclear antigen (PCNA) and Ki-67 antigen in laryngeal epithelial lesions. Oral Oncol 35 : 180 186.
12. Kusukawa J, Harada H, Shima I, Sasaguri Y, Kaneyama T, Morimatsu M (1996). The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer Oral Oncol 32B : 217 221.
13. Maiorano E, Favia G, Maisonnneuve, Viale G (1998). Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol 185 : 167 174.
14. Moore SR, Johnson NW, Pierce AM, Wilson DF (2000). The epidemiology of tongue cancer: a review of global incidence. Oral Dis 6 : 75 84.
15. Partridge M, Gullick WJ, Langdom JD, Sherriff M (1988). Expression of epidermal growth factor receptor in oral squamous cell carcinoma. Br J Oral Maxillofac Surg 26 : 381 389.
16. Pindborg JJ, Reichart PA, Smith CJ, van der Waal I (1997). Histological typing of cancer and precancer of the oral mucosa. Springer-Verlag : Berlin.
17. Sakai H, Kawano K, Okamura K, Hashimoto N (1990). Immunohistochemical localisation of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma. J Oral Pathol Med 19 : 1 4.
18. Schartinger VL, Kacani L, Ardle J, Schwentner I, Wurm M, Obrist P et al (2004). Pharmacodiagnostic value of the HER family in head and neck squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 66 : 21 26.
19. Shintani S, Li S, Mihara M et al (2003). Enhancement of tumour radioresponse by combined treatment with Gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer. Int J Cancer 107 : 1030 1037.
20. Shintani S, Li C, Mihara M et al (2004). Gefinitib ('Iressa', ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, upregulates p27KIP1 and induces G1 arrest in oral squamous cell carcinoma cell lines. Oral Oncol 40 : 43 51.
21. Sobin LH, Wittekind C eds (1997). UICC TNM classification of malignant tumours. 5th edn. Springer-Verlag : Berlin.
22. Störkel S, Reichert T, Reiffen KA, Wagner W (1993). EGFR and PCNA expression in oral squamous cell carcinomas - a valuable tool in estimating the patient's prognosis. Oral Oncol Eur J Cancer 29B : 273 277.
23. Ulanovski U, Stern Y, Roizman P, Shpitzer T, Popvtzer A, Feinmesser R (2004). Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue. Oral Oncol 40 : 532 537.
24. Xia W, Lau YK, Zhang HZ, Xia FY, Johnston DA, Liu AR (1999). Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5 : 4164 4174.
25. Yamada Y, Takagi M, Shioda S (1992). Evaluation of epidermal growth factor receptor in squamous cell carcinoma of the oral cavity. Oral Surg Oral Med Oral Pathol 73 : 67 70.